Old Web
English
Sign In
Acemap
>
authorDetail
>
Jane F. Apperley
Jane F. Apperley
Medical University of Vienna
Cancer research
Medicine
Imatinib
Biology
Relapsed chronic myelogenous leukemia
5
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
photopheresis for treatment of chronic graft-versus-host disease A multicenter prospective phase 2 randomized study of extracorporeal
2013
Robert Knobler
Jose Gallo
Andrea Bacigalupo
Hans Jochem Kolb
Luis Fernando Bouzas
Mauricette Michallet
H. Miles Prince
Mary E.D. Flowers
Jane F. Apperley
Koen van Besien
Ahmet H. Elmaagacli
A. Grigg
Show All
Source
Cite
Save
Citations (0)
prognostic relevance of the initial cell dose Donor lymphocyte infusion for relapsed chronic myelogenous leukemia
2010
Mauricette Michallet
Ahmet H. Elmaagacli
Alois Gratwohl
Jane F. Apperley
A.V.M.B. Schattenberg
Hans Jochem Kolb
A. Devergie
Andrea Bacigalupo
Cesare Guglielmi
William Arcese
Francesco Dazzi
Ronald Brand
Donald Bunjes
Leo F. Verdonck
Show All
Source
Cite
Save
Citations (0)
dasatinib after failing imatinib In vivo kinetics of kinase domain mutations in CML patients treated with
2010
Jane F. Apperley
Jaspal Kaeda
Valeria A. De Melo
Anna Babb
Eduardo Olavarria
David Marin
Jamshid S. Khorashad
Dragana Milojkovic
Puja Mehta
Mona Anand
Sara Ghorashian
G. Alistair
Show All
Source
Cite
Save
Citations (0)
Running title: MSC-mediated protection of CML cells from imatinib
2009
Fabrizio Vianello
Federica Villanova
Veronica Tisato
Stefania Lymperi
Ka-Kei Ho
Ana R. Gomes
David Marin
Dominique Bonnet
Jane F. Apperley
Francesco Dazzi
Show All
Source
Cite
Save
Citations (0)
Varying response to escalating the dose of imatinib in patients with CML who acquire a BCR-ABLM244V mutant allele
2006
Blood
Mona Anand
Jamshid Khorashad
David Marin
Jane F. Apperley
John M. Goldman
Jaspal Singh Kaeda
Show All
Source
Cite
Save
Citations (7)
1